Clinical trials
Recruiting Phase 2 Overweight trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
32 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2018 | 1 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 4 |
| 2025 | 11 |
| 2026 | 12 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 32 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 3 |
| Johns Hopkins University | 2 |
| AB Biotics, SA | 1 |
| AbbVie | 1 |
| Abdelrahman Mahmoud | 1 |
| Alveus Therapeutics, Inc. | 1 |
| BrightGene Bio-Medical Technology Co., Ltd. | 1 |
| Cairo University | 1 |
| ERX Pharmaceuticals | 1 |
| Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Overweight | 32 |
| Obesity | 29 |
| Prediabetic State | 3 |
| Body Weight | 2 |
| Diabetes Mellitus, Type 2 | 2 |
| Insulin Resistance | 2 |
| Metabolic Syndrome | 2 |
| Non-alcoholic Fatty Liver Disease | 2 |
| Weight Loss | 2 |
| Acquired Immunodeficiency Syndrome | 1 |
Trials
Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.